Clinical trial
The Use of Drugs to Improve Kidney Function in Patients With Liver and Kidney…
NCT00240045 · University of Alberta, Other · Completed
Key facts
| NCT number | NCT00240045 |
|---|---|
| Title | The Use of Drugs to Improve Kidney Function in Patients With Liver and Kidney Dysfunction |
| Official title | The Use of Midodrine, Octreotide and Albumin in Refractory Ascites |
| Lead sponsor | University of Alberta, Other |
| Collaborators | Novartis Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Type 2 Hepatorenal Syndrome, Refractory Ascites |
| Intervention type | Drug |
| Interventions | Midodrine, albumin, octreotide LAR, midodrine, octreotide |
| Enrollment | 9 |
| Start date | Oct 1, 2005 |
| Completion | Jul 1, 2007 |
| First posted | Oct 17, 2005 |
| Last update posted | Dec 6, 2007 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: